
Go or no go? Pandemic looms over FDA timelines
Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.
Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.